Pharmacokinetics of recombinant human c1 esterase inhibitor for treatment of hereditary angioedema attacks in children

Recombinant human C1 inhibitor (rhC1-INH) is indicated for the acute treatment of hereditary angioedema (HAE) attacks in adults/adolescents.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: A. Relan, A. Reshef, V. Grivcheva-Panovska, A. Kessel, S. Kivity, M. Klimaszewska-Rembiasz, D. Moldovan, H. Farkas, V. Gutova, S. Fritz, L. Bellizzi, B. Giannetti Tags: P165 Source Type: research